Back
Kalaris Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
KLRS
Kalaris Therapeutics, Inc.
Last Price:
$9.95
Seasonality Move:
-37.32%
7 Day Trial
ALL ACCESS PASS
$
7
Kalaris Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Kalaris Therapeutics, Inc. has on average historically fallen by 63% based on the past 5 years of stock performance.
-
Kalaris Therapeutics, Inc. has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Kalaris Therapeutics, Inc. Stock Undervalued?The current Kalaris Therapeutics, Inc. [KLRS] share price is $9.13. The Score for KLRS is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
KLRS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Kalaris Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Kalaris Therapeutics, Inc. has on average historically fallen by 63% based on the past 5 years of stock performance.
Kalaris Therapeutics, Inc. Stock Rating
Buy
61
Kalaris Therapeutics, Inc. (KLRS)
is a Buy
Is Kalaris Therapeutics, Inc. overpriced?
-
Kalaris Therapeutics, Inc. has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Kalaris Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
kalaristx.com
52-Week Data
52-Week High:
12.90
52-Week Low:
2.14
Prediction Charts
Market Cap:
170.8M
Price in USD:
9.13
Volume:
251.6K
Beta:
0.56
Technical Analysis
SMA50:
5.96
SMA100:
5.02
SMA200:
5.00
52-Wk Change:
-11.79%
Stock Predictions
-
Is Kalaris Therapeutics, Inc. stock public?Yes, Kalaris Therapeutics, Inc. is a publicly traded company.
-
What is the Kalaris Therapeutics, Inc. stock quote today?The Kalaris Therapeutics, Inc. stock price is 9.13 USD today.
-
How to buy Kalaris Therapeutics, Inc. stock online?You can buy Kalaris Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 5.47 | 5.47 | 5.80 | 5.10 |
| Dec-3 | 5.48 | 5.54 | 5.60 | 5.35 |
| Dec-4 | 5.54 | 5.92 | 6.00 | 5.33 |
| Dec-5 | 5.87 | 5.89 | 6.27 | 5.82 |
| Dec-8 | 5.92 | 6.16 | 6.25 | 5.58 |
| Dec-9 | 6.17 | 7.12 | 7.60 | 6.17 |
| Dec-10 | 7.11 | 7.57 | 7.70 | 7.10 |
| Dec-11 | 7.57 | 8.33 | 8.61 | 7.45 |
| Dec-12 | 8.45 | 8.87 | 8.87 | 7.82 |
| Dec-15 | 8.89 | 8.50 | 8.95 | 8.29 |
| Dec-16 | 8.45 | 8.66 | 8.84 | 8.30 |
| Dec-17 | 8.65 | 10.42 | 10.98 | 8.30 |
| Dec-18 | 10.84 | 10.42 | 11.88 | 9.98 |
| Dec-19 | 10.36 | 9.13 | 10.50 | 9.00 |
Kalaris Therapeutics, Inc. Earnings
Kalaris Therapeutics, Inc. Earnings Report: Per Share Kalaris Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Kalaris Therapeutics, Inc. Forecast Revenue Growth
Kalaris Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Kalaris Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.35 per share.
* Kalaris Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.